Richard Andrew Newcomb, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hematologic Neoplasms | 7 | 2024 | 1820 | 1.310 |
Why?
|
Hematopoietic Stem Cell Transplantation | 10 | 2024 | 5425 | 1.050 |
Why?
|
Lymphoma, B-Cell | 1 | 2021 | 930 | 0.480 |
Why?
|
Immunotherapy, Adoptive | 2 | 2024 | 1255 | 0.450 |
Why?
|
Quality of Life | 11 | 2024 | 12730 | 0.330 |
Why?
|
Leukemia, Myeloid, Acute | 4 | 2023 | 3497 | 0.280 |
Why?
|
Neoplasms | 7 | 2024 | 21596 | 0.260 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2021 | 1379 | 0.240 |
Why?
|
Neurotransmitter Agents | 2 | 1998 | 647 | 0.220 |
Why?
|
Ischemic Attack, Transient | 2 | 1998 | 934 | 0.190 |
Why?
|
Burkitt Lymphoma | 1 | 2023 | 328 | 0.190 |
Why?
|
Personal Satisfaction | 2 | 2024 | 634 | 0.190 |
Why?
|
Reperfusion Injury | 2 | 1998 | 1025 | 0.180 |
Why?
|
Hematologic Diseases | 1 | 2023 | 498 | 0.170 |
Why?
|
omega-Conotoxins | 1 | 1998 | 18 | 0.160 |
Why?
|
Antigens, CD19 | 1 | 2021 | 379 | 0.160 |
Why?
|
Carcinoma, Large Cell | 1 | 2018 | 113 | 0.160 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2021 | 491 | 0.150 |
Why?
|
Lymphoma, Follicular | 1 | 2021 | 435 | 0.150 |
Why?
|
Anxiety | 5 | 2024 | 4279 | 0.150 |
Why?
|
Fatigue | 2 | 2024 | 1526 | 0.140 |
Why?
|
Sarcopenia | 1 | 2021 | 368 | 0.130 |
Why?
|
Blood Coagulation | 1 | 2020 | 1126 | 0.120 |
Why?
|
Hospice Care | 1 | 2021 | 671 | 0.120 |
Why?
|
Palliative Care | 4 | 2024 | 3478 | 0.120 |
Why?
|
Extracellular Space | 1 | 1996 | 594 | 0.120 |
Why?
|
Potassium | 1 | 1998 | 1336 | 0.120 |
Why?
|
Hospitalization | 6 | 2024 | 10232 | 0.110 |
Why?
|
Adaptation, Psychological | 4 | 2024 | 2575 | 0.100 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2023 | 1596 | 0.100 |
Why?
|
Depression | 4 | 2024 | 7733 | 0.100 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2021 | 2524 | 0.100 |
Why?
|
Graft vs Host Disease | 1 | 2024 | 2951 | 0.100 |
Why?
|
Venous Thrombosis | 1 | 2020 | 1237 | 0.100 |
Why?
|
Humans | 28 | 2024 | 742088 | 0.100 |
Why?
|
Bone Marrow | 1 | 2021 | 2941 | 0.100 |
Why?
|
Acute Kidney Injury | 1 | 2023 | 1967 | 0.100 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 24913 | 0.090 |
Why?
|
Aged | 11 | 2023 | 162944 | 0.090 |
Why?
|
Terminal Care | 1 | 2021 | 1688 | 0.090 |
Why?
|
Amino Acids | 1 | 1996 | 1727 | 0.090 |
Why?
|
Middle Aged | 11 | 2024 | 213127 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2020 | 1668 | 0.080 |
Why?
|
Pulmonary Embolism | 1 | 2020 | 2370 | 0.080 |
Why?
|
Microdialysis | 2 | 1998 | 158 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2023 | 9185 | 0.070 |
Why?
|
Pilot Projects | 3 | 2024 | 8297 | 0.070 |
Why?
|
Patient Readmission | 1 | 2020 | 3111 | 0.070 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 4933 | 0.070 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10163 | 0.060 |
Why?
|
Male | 13 | 2024 | 349538 | 0.060 |
Why?
|
Immunotherapy | 1 | 2018 | 4414 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2018 | 4029 | 0.050 |
Why?
|
Survivors | 2 | 2023 | 2286 | 0.050 |
Why?
|
Bilirubin | 1 | 2023 | 424 | 0.050 |
Why?
|
Prospective Studies | 2 | 2023 | 53187 | 0.050 |
Why?
|
Renal Replacement Therapy | 1 | 2023 | 258 | 0.050 |
Why?
|
Bone Marrow Examination | 1 | 2021 | 157 | 0.050 |
Why?
|
Caregivers | 2 | 2023 | 2074 | 0.050 |
Why?
|
Cholecystitis | 1 | 2021 | 182 | 0.050 |
Why?
|
Female | 11 | 2024 | 379592 | 0.050 |
Why?
|
Rabbits | 2 | 1998 | 4886 | 0.050 |
Why?
|
Patient Satisfaction | 2 | 2024 | 3391 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 5171 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2024 | 1661 | 0.040 |
Why?
|
Patient Acceptance of Health Care | 2 | 2023 | 3014 | 0.040 |
Why?
|
Cyclophosphamide | 1 | 2023 | 2236 | 0.040 |
Why?
|
Mutation | 1 | 2021 | 29717 | 0.040 |
Why?
|
Patients | 1 | 2023 | 892 | 0.040 |
Why?
|
Retrospective Studies | 5 | 2023 | 77098 | 0.030 |
Why?
|
Adult | 7 | 2024 | 213712 | 0.030 |
Why?
|
Taurine | 1 | 1996 | 94 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2023 | 1369 | 0.030 |
Why?
|
Prognosis | 3 | 2020 | 29010 | 0.030 |
Why?
|
Abdominal Pain | 1 | 2021 | 1059 | 0.030 |
Why?
|
Body Temperature | 1 | 1998 | 776 | 0.030 |
Why?
|
Calcium Channel Blockers | 1 | 1998 | 689 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2018 | 13019 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1998 | 1574 | 0.030 |
Why?
|
Aspartic Acid | 1 | 1996 | 574 | 0.030 |
Why?
|
Qualitative Research | 1 | 2022 | 2680 | 0.030 |
Why?
|
Basal Ganglia | 1 | 1996 | 545 | 0.030 |
Why?
|
Cerebrospinal Fluid | 1 | 1996 | 534 | 0.030 |
Why?
|
Social Support | 1 | 2022 | 2117 | 0.030 |
Why?
|
Inpatients | 1 | 2024 | 2495 | 0.030 |
Why?
|
Medication Adherence | 1 | 2023 | 2055 | 0.030 |
Why?
|
Critical Illness | 1 | 2023 | 2665 | 0.020 |
Why?
|
Cerebral Cortex | 2 | 1998 | 5705 | 0.020 |
Why?
|
Glutamic Acid | 1 | 1996 | 1167 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2023 | 3679 | 0.020 |
Why?
|
gamma-Aminobutyric Acid | 1 | 1996 | 1123 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8333 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6756 | 0.020 |
Why?
|
Patient Discharge | 1 | 2020 | 3300 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2023 | 13921 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2024 | 9941 | 0.020 |
Why?
|
Analysis of Variance | 1 | 1996 | 6365 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 7901 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2021 | 5851 | 0.020 |
Why?
|
Regression Analysis | 1 | 1996 | 6452 | 0.020 |
Why?
|
Peptides | 1 | 1998 | 4392 | 0.020 |
Why?
|
Incidence | 1 | 2023 | 20928 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2020 | 57683 | 0.020 |
Why?
|
Survival Rate | 1 | 2018 | 12773 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 11472 | 0.010 |
Why?
|
Age Factors | 1 | 2018 | 18355 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 23320 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39004 | 0.010 |
Why?
|
Adolescent | 1 | 2024 | 85649 | 0.010 |
Why?
|
Young Adult | 1 | 2022 | 56350 | 0.010 |
Why?
|
Animals | 2 | 1998 | 168561 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 72145 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 62966 | 0.010 |
Why?
|